Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China · Delayed Price · Currency is CNY 70.26
+0.89 (1.28%)
May 8, 2026, 3:04 PM CST
SHE:300573 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 756.37 | 695.86 | 338.06 | 240.04 | 211.68 | 194.7 |
Depreciation & Amortization | 110.27 | 110.27 | 102.5 | 88.81 | 74.37 | 67.28 |
Other Amortization | 5.01 | 5.01 | 4 | 4.53 | 5.65 | 6.21 |
Loss (Gain) From Sale of Assets | -0.05 | -0.05 | 0.98 | 0.04 | -0.42 | -5.16 |
Asset Writedown & Restructuring Costs | 3.7 | 3.7 | 14.05 | - | 0 | 0 |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -3.14 |
Provision & Write-off of Bad Debts | 1.08 | 1.08 | 3.32 | 3.03 | 0.93 | -0.19 |
Other Operating Activities | -23.52 | 19.17 | 10.54 | 10.23 | 5.53 | 24.49 |
Change in Accounts Receivable | -174.85 | -174.85 | -144.42 | -104.38 | -37.51 | -33.43 |
Change in Inventory | -47.6 | -47.6 | -20.99 | -22.05 | -34.35 | -27.8 |
Change in Accounts Payable | 129.83 | 129.83 | 95.54 | 73.17 | 23.51 | 73.27 |
Change in Other Net Operating Assets | 6.6 | 6.6 | 11.55 | 23.42 | 42.47 | 13.31 |
Operating Cash Flow | 771.21 | 753.39 | 416.98 | 317.57 | 286.26 | 306.96 |
Operating Cash Flow Growth | 47.13% | 80.68% | 31.30% | 10.94% | -6.74% | 151.28% |
Capital Expenditures | -263.81 | -270.53 | -198.71 | -261.96 | -299.23 | -95.06 |
Sale of Property, Plant & Equipment | 0.05 | 0.05 | 0.33 | 0.02 | 0.08 | 19.03 |
Divestitures | - | - | - | - | - | 1.26 |
Investment in Securities | - | - | -10 | - | - | -130.24 |
Other Investing Activities | 0.34 | 0.74 | -7.28 | - | - | 3 |
Investing Cash Flow | -263.42 | -269.74 | -215.67 | -261.94 | -299.15 | -202.01 |
Short-Term Debt Issued | - | 181 | 310 | 70 | 20 | 100 |
Total Debt Issued | 101 | 181 | 310 | 70 | 20 | 100 |
Short-Term Debt Repaid | - | -311 | -180 | - | -120 | -80 |
Long-Term Debt Repaid | - | -11.66 | -8.93 | -7.67 | -6.17 | -8.7 |
Total Debt Repaid | -222.66 | -322.66 | -188.93 | -7.67 | -126.17 | -88.7 |
Net Debt Issued (Repaid) | -121.66 | -141.66 | 121.07 | 62.33 | -106.17 | 11.3 |
Issuance of Common Stock | 19.22 | 19.22 | 22.17 | 25.3 | 27.56 | 580.18 |
Repurchase of Common Stock | -22.16 | -22.16 | -0.32 | -16.81 | - | -0.27 |
Common Dividends Paid | -349.98 | -351.08 | -466.57 | -178.49 | -80.84 | -47.13 |
Other Financing Activities | 36.35 | 37.3 | 4.87 | 23.5 | 1.02 | -5.95 |
Financing Cash Flow | -438.24 | -458.39 | -318.79 | -84.17 | -158.42 | 538.12 |
Foreign Exchange Rate Adjustments | -0.68 | -1.67 | -0.11 | 0.2 | -0.09 | -0.13 |
Net Cash Flow | 68.87 | 23.59 | -117.58 | -28.34 | -171.4 | 642.94 |
Free Cash Flow | 507.4 | 482.86 | 218.27 | 55.61 | -12.96 | 211.9 |
Free Cash Flow Growth | 59.84% | 121.22% | 292.54% | - | - | 1412.86% |
Free Cash Flow Margin | 19.37% | 19.53% | 11.23% | 3.79% | -1.04% | 20.61% |
Free Cash Flow Per Share | 2.07 | 1.96 | 0.89 | 0.23 | -0.05 | 0.94 |
Cash Income Tax Paid | 337.92 | 308.88 | 215.15 | 109.68 | 134.28 | 103.23 |
Levered Free Cash Flow | 426.52 | 446.06 | 206.99 | -22.52 | -104.31 | 127.3 |
Unlevered Free Cash Flow | 428.65 | 448.83 | 210.56 | -21.62 | -103.72 | 131.04 |
Change in Working Capital | -81.65 | -81.65 | -56.47 | -29.11 | -11.49 | 22.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.